Harvard Bioscience, Inc. (HBIO)
5.31
-0.26
(-4.58%)
USD |
NASDAQ |
May 14, 11:38
Harvard Bioscience Cash from Investing (Quarterly) : -0.62M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -93.00M |
| Bio-Rad Laboratories, Inc. | -93.20M |
| Bruker Corp. | -39.70M |
| Azenta, Inc. | -114.75M |
| Revvity, Inc. | -78.27M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.791M |
| Cash from Financing (Quarterly) | 0.12M |
| Free Cash Flow | 1.281M |
| Free Cash Flow Per Share (Quarterly) | -0.3154 |
| Free Cash Flow to Equity (Quarterly) | 6.655M |
| Free Cash Flow to Firm (Quarterly) | 0.3781M |
| Free Cash Flow Yield | 5.42% |